Concentra Group Holdings Parent, Inc. - Q1 2025 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2025. Concentra Group Holdings Parent, Inc. (Concentra) is the largest provider of occupational health services in the United States by number of locations. As of March 31, 2025, the Company operated 627 stand-alone occupational health centers in 41 states and 160 onsite health clinics in 36 states. The Company became a fully independent public entity following a special stock distribution from Select Medical Corporation on November 25, 2024.
Key Financial Metrics
| Metric | Q1 2025 | Q1 2024 |
|---|---|---|
| Revenue | $500.8 million | $467.6 million |
| Net Income (GAAP) | $40.6 million | $50.3 million |
| Net Income Attributable to Company | $38.9 million | $49.0 million |
| Diluted EPS | $0.30 | $0.47 |
| Adjusted EBITDA | $102.7 million | $96.1 million |
| Operating Cash Flow | $11.7 million | $44.6 million |
| Total Debt (Carrying Value) | $1.63 billion | $1.48 billion |
| Cash and Equivalents | $52.1 million | $49.6 million |
Liquidity: As of March 31, 2025, the Company had $386.4 million of availability under its Revolving Credit Facility. Net working capital decreased to $31.2 million from $130.0 million at year-end 2024, primarily due to cash used for the Nova acquisition.
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 7.1% year-over-year, driven by a 5.6% increase in revenue per visit (due to higher reimbursement rates and employer service rates) and the acquisition of 72 occupational health centers in March 2025.
- Profitability Decline: Net income attributable to the Company decreased 20.5% to $38.9 million. This was primarily due to a significant increase in interest expense ($25.5 million in Q1 2025 vs. $0.1 million in Q1 2024) following the July 2024 recapitalization and March 2025 debt amendments.
- Acquisition Activity: The Company acquired Nova Medical Centers for approximately $265 million on March 1, 2025. This transaction added 67 centers and resulted in $3.1 million in acquisition costs and a $0.9 million loss on early retirement of debt.
- Operating Cash Flow: Operating cash flow decreased significantly to $11.7 million from $44.6 million, largely attributed to increased interest payments and changes in working capital.
Outlook, Risks, and Unusual Items
- Future Acquisitions: On April 18, 2025, the Company entered an agreement to acquire Pivot Onsite Innovations for $55 million, expected to close in Q2 2025. This will expand onsite clinics to over 350 locations.
- Dividend: The Board declared a cash dividend of $0.0625 per share, payable May 29, 2025.
- Debt Structure: In March 2025, the Company amended its Credit Agreement to increase the Revolving Credit Facility to $450 million and added a $102.1 million incremental term loan. Interest rates on these facilities were reduced to Term SOFR + 2.00%.
- Risks and Contingencies:
- Litigation: The Company is subject to a California Department of Insurance investigation regarding billing and coding for physical therapy claims. Additionally, consolidated class action lawsuits are pending regarding a 2023 data breach at a third-party vendor (Perry Johnson & Associates).
- Regulatory: Risks include changes to state fee schedules, workers' compensation regulations, and potential impacts from new U.S. tariff policies.
Investor Verification Checklist
- Debt Servicing Capacity: Verify the impact of the increased interest expense ($25.5M in Q1) on future cash flows and the ability to service the $1.63 billion debt load.
- Acquisition Integration: Monitor the integration of the Nova Medical Centers acquisition and the pending Pivot Onsite Innovations deal to ensure projected synergies and revenue growth materialize.
- Reimbursement Rates: Confirm the sustainability of the 5.6% increase in revenue per visit, which was driven by state fee schedule changes and rate increases.
- Litigation Exposure: Track the status of the California insurance investigation and the Perry Johnson data breach litigation for potential material financial impact.
- Working Capital Trends: Observe the sharp decline in net working capital ($130M to $31M) and ensure liquidity remains sufficient for operations and future M&A.